awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33648344-9677F94E-C336-4F41-9807-DD5D97685AC7
Q33648344-9677F94E-C336-4F41-9807-DD5D97685AC7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33648344-9677F94E-C336-4F41-9807-DD5D97685AC7
Bortezomib salvage followed by a Phase I/II study of bortezomib plus high-dose melphalan and tandem autologous transplantation for patients with primary resistant myeloma
P2860
Q33648344-9677F94E-C336-4F41-9807-DD5D97685AC7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33648344-9677F94E-C336-4F41-9807-DD5D97685AC7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0207ad96c43ced2cfb2ce47faed29ce5bcbaf61a
P2860
A phase I/II trial combining high-dose melphalan and autologous transplant with bortezomib for multiple myeloma: a dose- and schedule-finding study.